Many patients are interested in this path because they want to reduce their reliance on harsh immunosuppressive drugs
Secondary prevention of cardiovascular disease in high-risk patients diagnosed with cardiovascular disease (status post myocardial infarction or stroke, peripheral arterial disease), type 2 diabetes, or moderate to severe chronic kidney disease (CKD 4-5): in patients who cannot be diagnosed with FH according to Dutch criteria, although they have lipid disorders and do not achieve their LDL-C targets, according to the adopted guidelines (), and in whom all other standard therapies have failed (for at least 3 months) or are poorly tolerated, and/or there are contraindications to pharmacological treatment (adverse effects, complications, e.g
107 , as we have reported previously 24
In general, results have shown that: Appetite suppression can start in the first week
I'm throwing it your way
doi:10.1016/j.molmet.2018.09.009 What is Tirzepatide (5 mg)